What is SoftGenetics?
SoftGenetics operates at the intersection of artificial intelligence and bioinformatics, offering a scientific intelligence platform tailored for genetic analysis, forensic DNA analysis, and healthcare applications. Their comprehensive product suite encompasses software for sequencing, mutation analysis, and advanced bioinformatics, empowering researchers and professionals with tools for statistical analysis, graphing, and electronic lab notebook functionalities. The company emphasizes speed, accuracy, and user-friendly interfaces to enhance scientific discovery and data organization within the research community.
How much funding has SoftGenetics raised?
SoftGenetics has raised a total of $439K across 2 funding rounds:
Debt
$150K
Debt
$289K
Debt (2020): $150K with participation from PPP
Debt (2021): $289K led by PPP
Key Investors in SoftGenetics
PPP
Public-Private Partnership
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for SoftGenetics?
With its recent strategic investment and substantial total funding of $439K, SoftGenetics is well-positioned for its next phase of growth. The company's focus on AI-driven data management and workflow automation in critical areas like genetic analysis suggests a trajectory towards expanding its market reach and deepening its technological capabilities. This capital will likely fuel further research and development, enabling SoftGenetics to enhance its platform and address the evolving needs of the scientific and healthcare industries, potentially leading to broader adoption and new strategic partnerships.
See full SoftGenetics company page
